Phototherapeutic apparatus for newborns

FIELD: medicine.

SUBSTANCE: invention refers to medical equipment, namely to phototherapeutic apparatuses for newborns. A first embodiment of the apparatus comprises a body assembly having a connection site, a light source, a lock switch for locking and unlocking an operating status of the light source, a positional light mode adapter selectively detachably connected to the body assembly at the connection site. The attachment of the adapter to the connection site switches the lock switch from the blocking configuration in the unlocking configuration; the disconnection of the adapter switches the lock switch. A panel lighting mode assembly comprises a lighting panel mode adapter detachably connected to the body assembly at the connection site, and a light guide connected to a light-emitting panel. In the second version, there is a LED-assembly in the blue range of the visible spectrum inside the body assembly between its opposite ends to emit light from one end of the body assembly. The body assembly has a central portion of a smaller diameter and the connection site in the centre of an end element with a hole to accommodate a detachably connected positional light mode adapter or the panel lighting mode adapter. In the third version, a circuit board is connected to the LED-assembly. The opposite ends of the body assembly comprise the inlet and outlet air tubes, a fan to circulate the air in the longitudinal direction through the inlet, intermediate and outlet tubes. In the fourth version, the panel lighting mode assembly further comprises an elongated flexible light guide and light-emitting panel, and a suspension construct for suspending the body assembly, wherein when the lighting panel mode adapter is disconnected from the body assembly, and the positional light mode adapter is disconnected from the body assembly, no light is emitted from the body.

EFFECT: use of the invention allows extending the range of the phototherapeutic apparatuses.

23 cl, 13 dwg

 

CROSS-REFERENCE TO RELATED APPLICATIONS

In accordance with § 119(e) of section 35, United States Code, for the present application claims Convention priority on provisional application for U.S. patent No. 60/961754, filed July 24, 2007, the contents of which are entirely included in the present description by reference.

The prior art INVENTIONS

The technical field to which the invention relates.

The present invention relates to phototherapy devices and, in particular, to phototherapy devices for babies, made with phototherapy babies.

Description of the prior art

Known phototherapy devices that produce radiant energy, usually visible light having a specific wavelength, and which transmit energy to the surface of the patient. In phototherapy device of one type of light from a halogen lamp is transferred to the surface of the patient for the treatment of jaundice. An example of this conventional phototherapy device is phototherapy system Wallaby®, supplied by Respironics Inc., Pittsburgh, PA.

Such conventional phototherapy devices typically include a light source and a fiber optic cable having a proximal end associated with the light source for transmitting light to the patient. At the distal the end of the fiber optic cable is a fiber optic panel for providing svetodiodah blankets, which can be positioned near the patient's skin. The device is suitable for the treatment of infants, especially newborns suffering from jaundice.

The INVENTION

The present invention provides several improvements over known phototherapy devices. In accordance with one aspect of the present invention offers a phototherapy device for babies, containing Cabinet Assembly containing the connecting seat; a light source installed in the Cabinet Assembly and configured to emit light from the Cabinet Assembly; the locking switch, perform the function of locking and unlocking the operational state of the light source; adapter mode local lighting made with the possibility of selective detachable connection with a Cabinet Assembly in connection with the attachment of the adapter-mode local light to the connecting seat switches locking switch from the blocking configuration in debateroom configuration, and removing the adapter-mode local light switches locking switch from deblokiruyuschee configuration to the locking configuration, and, when the adapter-mode local light attached to the connecting seat, the light from the source of the light can be emitted from the housing; site and mode panel lighting containing adapter mode panel lighting, and the adapter mode panel lighting is made with the possibility of permanent connection with the Cabinet Assembly in connection with the node of the mode panel lighting includes an elongated flexible optical fiber connected at one end with the adapter mode panel lighting and, at the opposite end, with a light-emitting panel, and the node of the mode panel lighting provides light communication through a flexible light guide between the light source and the light-emitting panel, when the adapter mode panel lighting attached to the connecting place.

In accordance with another aspect of the present invention offers a phototherapy device for babies, containing Cabinet Assembly and LED (led) Assembly, made with the possibility of light emission in the blue range of the visible spectrum; this LED Assembly is installed inside the Cabinet Assembly between its opposite ends, to emit light from one end of the Cabinet Assembly when power is applied; Cabinet Assembly has, in General, a cylindrical outer surface, but with the Central section of smaller diameter than the opposite areas of said surface.

In accordance with another aspect of the present invention offer the W phototherapy device for infants containing Cabinet Assembly and an LED Assembly that, when powered, provides a light source having a power output in the blue range of the visible spectrum; this LED Assembly is installed inside the Cabinet Assembly between its opposite ends; a circuit Board electrically connected with the LED Assembly installed inside the tank site near the LED Assembly; dip switch on the Cabinet Assembly, electrically connected with said circuit Board so as to control the supply of power to the LED Assembly; and the opposite ends of Cabinet assemblies contain fulfilled in them the intake and exhaust air ducts, LED the Assembly includes structure for mounting the LED, providing an intermediate passage between the inlet and outlet channels, and the fan is electrically connected to the circuit Board and installed in the Cabinet Assembly in position, providing circulation of air sequentially through the inlet, intermediate and outlet channels.

In accordance with another aspect of the present invention offers a phototherapy device for babies, containing a manually portable housing Assembly; an LED light source located inside the Cabinet Assembly and capable of emitting light in the blue range of the visible spectrum; the design in the form of handbags that are made with the option to retrieve and reliable placement of her Cabinet Assembly, without interference of the light emitted to the outside of the Cabinet Assembly LED light source; the design for the bag includes a mounting strap connected with the said design.

In accordance with another aspect of the present invention offers a phototherapy device for babies, containing Cabinet Assembly; a light source installed in the Cabinet Assembly; node mode panel lighting containing adapter mode panel lighting made with the possibility detachable connection with the Cabinet Assembly, and the host mode panel lighting further comprises an elongated flexible light guide and the light-emitting panel, the light guide provides a light connection between the light source and the light-emitting panel so that, when the adapter mode panel lighting connected to the Cabinet Assembly, the light emitted from the light source, transmitted through the light in the light-emitting panel; the design of the suspension made with the possibility of hanging Cabinet Assembly, and, when the adapter mode panel lighting disconnected from the Cabinet Assembly Cabinet Assembly suspended on the suspension design, light emitted from the housing can be projected on the patient.

Data and other objectives, features and characteristics of the present invention, as well as methods of operation and function is related elements of construction and combinations of parts, and economy of manufacture will become more understandable from the description and the attached claims below with reference to the accompanying drawings, all of which are part of the present description and in which the same numeric position indicate corresponding parts in the various figures. However, it should be clearly understood that the drawings are only for illustration and description and are not intended to delimit the scope of the invention. In the context of the present description and claims, the singular includes reference to the plural, unless the context clearly does not prescribe otherwise.

BRIEF DESCRIPTION of DRAWINGS

Figure 1 is a perspective view phototherapy device for babies, carrying out one aspect of the present invention, the device is shown in its mode panel lighting wrapped around the infant;

Figure 2 is a perspective view phototherapy device for infants, individually;

Figure 3 is a perspective view similar to the view of figure 2, with the image of the cover panel, used for covering node panel during treatment;

Figure 4 is a perspective view depicting the interface between the Cabinet Assembly of the device and the design phase of a suspension for use in local mode lit is I;

Figure 5 is a perspective view of the device showing the design of the suspension in position when the device is in local mode coverage;

Figure 6 is a perspective view of Cabinet Assembly device in accordance with the present invention, showing the adapter mode panel lighting before inserting the housing Assembly;

Figure 7 is a perspective view similar to figure 6 showing the adapter mode panel lighting, partially inserted into the housing Assembly;

Figure 8 is a perspective view similar to figure 6 showing the adapter mode panel lighting in conjunction with the Cabinet Assembly;

Figure 9 is a perspective view of Cabinet Assembly with the upper paucorum Cabinet Assembly removed to show the internal parts inside Cabinet Assembly, while the inner part of the circuit Board is also removed for clearer illustration;

Figure 10 is an enlarged detail view in section, taken along the line 10-10 in figure 9, representing the tail section of the adapter Cabinet Assembly containing parts, taken on the figure 9, but with the adapter-mode local light attached to the Cabinet Assembly.

Figure 11 is a view in section, taken along the line 11-11 in figure 9, representing the connection of the lower frame polyosoma with the upper body paucorum; and

Figures 12 and 13 species in the PE the perspective corps site in position before it is inserted in two different implementation designs of bags, carrying out one aspect of the present invention.

DETAILED DESCRIPTION of EXEMPLARY embodiments

In particular, in figure 1 of the drawings shows a phototherapy device for infants, the overall position 10, which carries out various aspects of the present invention. The device 10 can be selectively applied in one of two modes, panel lighting, shown in figure 1, and the mode of local illumination, shown in figure 5.

The device 10, as shown in figures 1-2, contains, in General, Cabinet Assembly, indicated the General position 12, which contains therein a source 14 of therapeutic light (see figure 9 and 10). In one embodiment, the source 14 of the light may include at least one light-emitting diode (LED). LED source 14 of the light can be output intensity higher than 55 mW/cm2/nm, lifetime more than 600 hours, and emits light with a wavelength in the blue range of the visible spectrum. In one embodiment, the light source has an output power of 85 mW/cm2/nm and the service life of 35,000 hours. However, you can also apply other known light sources suitable for the treatment of jaundice. For example, you can use halogen or fluorescent light sources, as suggested, for example, in patent '899.

In the time mode panel lighting, as shown in figure 1, the device 10 contains a node 15 mode panel lighting containing elongated flexible light guide unit or the light guide 16, the node 18 of the flexible light-emitting panel and the adapter 22 mode panel lighting. The adapter 22 mode panel lighting has a distal end that can be connected to the body node 12 with the connector in the connecting seat 13 and capable of transmitting light from the light source 14 of the light inside the Cabinet Assembly 12. Thus, it can be ensured length relationship between the source 14 and the light from the optical fiber 16 through the adapter 22 mode panel lighting, which has a cylindrical configuration and hollow the Central channel and the optical fiber 16 from the hub 18 of the panel. In one embodiment, the light guide 16 may include at least one fiber-optic cable or a single fiber. As the optical fiber 16, and the node 18 of the panel may be of a type that is known in the art and described in the aforementioned U.S. patent No. 6494899 included in the description by reference.

The figure 3 shows the typical soft pouch or envelope 20 having a hole 21 at one end to accommodate the node 18 of the panel so that it is more convenient to place the baby during treatment. The cover or envelope 20 is disposable and may be permeable to the light emitted by the panel 18, so that the light could be perceived skin MAV is Inza.

As best shown in figure 1, the device 10, shown in its mode panel lighting, useful for the treatment of jaundice of infants and, in particular, newborn. The mode panel lighting involves wrapping the baby in the node 18 of the panel (optional, closed the case 20) and then feed the power source 14 of the light within a predefined period, which can be determined by the doctor.

In the mode panel lighting adapter 12 mode panel lighting is used as an interface between the node 15 mode panel lighting and Cabinet Assembly 12 and, in one embodiment, can be applied to release the locking of the switch, as described in further.

As best shown in figures 4 and 5, in the local mode of lighting you can use the node 23 of the local lighting. Node 23 local lighting contains adapter local lighting, the overall position 24, and the construction of 26 suspension. The adapter 24 local lighting connects to the Cabinet Assembly 12 in the connecting seat 13 and connects the Cabinet Assembly 12 with the construction of 26 suspension. As shown in figure 5, the construction of 26 suspension contains the installation element 28, which is connected with an adjustable hinge unit 30. Adjustable hinge block 30 includes a pair of coupling ele the clients 32 and 34, pivotally connected by a swivel 36. The pivot joint 36 can be shut by a rotating element 38 of the handle in one direction, so that the elements 32 and 34 can be rotated one relative to another, and clamp by turning the element 38 of the handle in the opposite direction to lock the elements 32 and 34 are rotated one relative to another in the positions in which displaced mentioned elements.

Design 26 suspension contains two intermediate adjustable hinge unit 40 and 42, both structurally is identical to the block 30. The hinge unit 40 is connected with the hinge unit 30 is an elongated tubular or rod element 43. Similarly, the hinge block 42 engages with the pivot block 40 of tubular or rod element 44. Design 26 suspension connects to the adapter 24 local lighting adjustable universal swivel block 48. As shown in figure 4, block 48 contains a ball bearing 50, spatially fixed with respect to the outer side of the adapter 24 local lighting rod 51. Swivel block 48 also includes a movable clamping element 52 is fixed with the ability of the brakes to the ball socket 50 of the drive handle 54. Swivel block 48 is connected with the pivot block 42 of the tubular or rod element 46.

During operation, the local lighting adapt the R 24 local lighting, in rigid connection with the Cabinet Assembly 12 provides the hole 25, thanks to its tubular design (see figures 4 and 10), for the passage of light emitted by the source 14 of the light. The proper direction of light emitted from a Cabinet Assembly in the mode of local lighting, it is possible to provide adjustment of the adjustable blocks 30, 40, 42 and/or 48 after the clip mounting element 28 in a fixed position relative to a bed, cot or other support structure. Design 26 suspension can have many different forms, such as, in one embodiment, the above structure is only required to suspend, to fix or position the Cabinet Assembly 12 for use in local mode lighting (i.e. lighting of baby's skin without the use of node 15 mode panel lighting).

Cabinet Assembly 12 may be of any suitable design, shape or configuration. In one embodiment, housing Assembly perform so as to provide light weight (for example, from molded plastic or elastomeric material and easy to carry from place to place with one hand. Cabinet Assembly 12, as shown, has, in General, a smooth outer surface 56 of the grip located between the opposite end elements 58 and 60. The configuration of the surface 56 of capture is, in General,a cylindrical or tubular between the opposite end elements 58 and 60 Cabinet Assembly 12 and has a Central area smaller circumference, than the opposite ends, which allows the user to easily catch and hold the Cabinet Assembly 12 with one hand with ease to carry.

As best shown in the embodiment in figures 9 and 10, the design of the Cabinet Assembly 12, which provides a surface 56 of the gripper comprises upper and lower molded plastic coupling polakowi 62 and 64. As shown in figure 11, polakowi 62 and 64 have mating edges 66 and 68 along their mating edges. As shown in figure 10, the ends Polukarov 62 and 64 bit are bent inward to overlap the outer circumference of the respective end elements 58 or 60 (figure 10 shows only the element 58). The said ends contain formed in the internal annular groove 71 for placing the opposite annular projections 70 formed on the periphery of the end elements 58 and 60. In one embodiment, the Cabinet Assembly 12 has the shape of an hourglass. Of course, you can use many various other forms without deviating from the principles of the present invention. For example, the device may have a stepped configuration, or even an ergonomic configuration that is arranged to fit to the hand of the user. The hourglass shape provides two facing one another conic section that d is allowed their comfortable grip by the user. End items of a larger size reduces the likelihood of slipping of the device and the user's hands. In addition, the authors of the present invention suggest that this form can also be comfortable to grip under the shoulder of the user and holding the armpit of the user, between the shoulder and side, when it is desirable to have the possibility of carrying.

As shown in figures 9-11, the source 14 of the light is contained within the body node 12. In one embodiment, as noted above, the source 14 of light includes at least one LED. In particular, as shown, may be provided with the LED Assembly 72. In addition, inside the body node 12 is the node 74 of the fan for cooling the LED Assembly 72 and the circuit Board 76 that contains a controller which controls the operation of the source 14 of light (or LED-Assembly 72 and node 74 of the fan. The controller on the circuit Board 76 is functionally associated with the interlock switch 78 and an on / off switch 80, as explained next. The controller may be a processor of any type containing any combination of hardware and/or software. Alternatively, the controller may simply contain circuit elements to create opportunities interconnects and functioning of the switches 78, 80, source 14 and light node 74 of the fan.

In one embodiment, CE and, implemented in the device 10, may include some or all of the principles described in U.S. patent No. 6494899.

The lock switch 78 (see Fig. 10) contains contact element 79 to actuate the switch 78. The switch 78 is electrically connected to circuit Board 76 so that, when the actuation (for example, the introduction of the contact of the contact element 79), dip switch 80 located within the openings 82 in the surface 56 of the engagement, could perform the function of controlling the supply of power to the LED Assembly 72 and node 74 of the fan. On the other hand, as explained hereinafter, when the lock switch 78 is not actuated, two-position switch 80 is blocked so that the LED source 14 to enable the impossible.

Dip switch 80 includes a switch device 81 and a push button 83. Dip switch 80 may be any known in the art type. However, in another embodiment, provided that no two-position switch 80 can be dispensed with, and the source 14 and the light will turn on whenever one of the adapters 22 or 24 engages with the contact element 79 of the locking switch 78. The source 14 of the light in this embodiment (without dip switch 80) is turned off when the adapter is directed by the mA is not installed.

The power source for the nodes 72 and 74 is a common source of alternating current connected with the circuit Board 76 electric cable 84, which continues through the Central section of the end element 60 Cabinet Assembly 12. However, you can also use any power source, such as a constant current source or a rechargeable battery.

As best seen in figure 10, the Cabinet Assembly 12 includes a window 86 in the surface 56 of the grip, at the position opposite to the hole 82. The display 88, which may be in the form of a liquid crystal display (LCD), the display light emitting diodes (LED-display) display or other type, is located in position for observation through the window 86. The display 88 may be connected to the timer or the clock provided on the circuit Board 76 for time representation of the device, i.e. the total "on-time" source 14 light since the last key-off switch 80. In one embodiment, the timer or the clock will be reset whenever the switch 80 is turned off. In another embodiment, the display may also or alternatively display the total time of operation in hours LED Assembly 72, regardless, does the action of the locking switch 78, and regardless of whether the two is positiony switch 80.

Casing part 58, 60, 62 and 64 and the inner part 72, 74, 76, 78, 80 and 88 formed as a monolithic structure by gluing or other binders or, in the alternative implementation, can be connected by a snap fit, screw connection or by any conventional connection.

LED Assembly 72 includes a mounting structure 90 for LED containing continuing through air channels 92 and still installed in the center of the internal space of the lower frame polyosoma 64 in position directly above the LCD display 88 digital display. On the lower hull polokiuk 64, around the mounting structure 90 for LED fixed node 74 of the fan in the position of drawing air through the air channels 92 of the mounting structure 90 for LED.

Air drawn through the air channels 92 of the mounting structure 90 for LED goes outside Cabinet Assembly 12 and is drawn through a group of air channels 94 (see figures 9 and 10)formed in the annular area of the end of element 58, before the air reaches the air channels 92. Air drawn through the air channels 92, is pumped out of the body node 12 node 74 of the fan through a group of channels 96 formed in the annular zone of the end element 60 (see figure 9).

Circuit Board 76, dip switch 80, Bakirova the ing switch 78, all first attached to the upper vessel Polukarov 62. After each hull polokiuk 62 and 64 secured their respective internal parts, polakowi can be reduced and glue or otherwise fasten the grip of shelves 66 and 68. It should be noted that when squaring polakowi 62 and 64, circuit Board 76 is moved to the position in which it rests on a series of vertical struts 97, formed integral with the lower paucorum 67 and continued it up (see figure 11).

As shown in figure 9, the center end of the element 58 defines a connecting seat 13 for selective connection of any one of the adapters 22 and 24. For this purpose, in the center of the end of element 58 is formed an annular connecting section 98, axially protruding outward and having an inner surface 100, a limiting hole 103, the host adapter, the end element. The upper rim 101 of the connecting section 98 and the inner surface 100 is limited by the internal cut-out or groove 102 formed in them.

As you can see from figures 6-8 and 10, each of the adapters 22 and 24 comprises a tubular front section 104 of size, is made to enter into the hole 103, a limited internal surfaces 100. The rear end of each tubular section 104 is limited by a shoulder 106, continuing radially outward or retaining the surface, which traveler goes into constituting one tubular section 108 with a larger diameter (see figure 6). At some distance from the shoulder 106 of the outer surface of each of the front tubular section 104 extends outside foot 110 intended to enter the notch 102.

The adapter 22 mode panel lighting attached to the proximal end of the light guide node 16 so that when you want to apply the device 10 in the mode panel lighting, adapter 22 with the attached node 16, is positioned for insertion through the hole, limited internal surfaces 100, as shown in figure 6. Then the front section 104 of the adapter 22 mode panel lighting is inserted into the hole 103 limited by surfaces 100 and, thus, provide a combination of 110 feet with a cutout 102, as shown in figure 7. Then, in this position, the adapter 22 can be entered inside, until the shoulder 106 will not come into contact with the end surface 101 of the speaker connecting section 98. Finally, a small rotation of the adapter 22, the foot 110 to rotate the inner flange (not shown), bounded by surfaces 100, to complete the fixed connection, as shown in figure 8.

In figure 10 you can see, in particular, that, when any of the adapters 22 and 24 move in connection with the body node 12 as described is of higher the upper front end of the front tubular section 104 of the adapter (either 22 or 24) will pass through the space inside the body node 12, which are engaged by the contact element 79 of the locking switch 78 to engage with the contact element 79 and thereby enable the operation of the LED Assembly 72. In particular, when both of the adapter 22 and 24 when separated from the housing 12, the locking switch 78 is in the normal blocking state and is electrically connected to circuit Board 76 so as not to allow the power supply to the LED Assembly 72 and node 74 of the fan, even if dip switch 80 is moved to its engaged position. Therefore, the LED Assembly 72 may not be powered until one or the other of the adapters 22 or 24 is not connected, as described above, with the Cabinet Assembly 12. As a result, the device 10 can be sold to a caregiver, along with the adapter 22 mode panel lighting and design, 16, 18 and 20 for mode panel lighting for use in the home. The adapter 24 local lighting and its design 26 suspension usually kept for use in hospitals. Hospital use is more versatile, because the device 10 can be applied either in the mode panel lighting, or local lighting.

It should be understood that lakirovanie switch 78 may be of any type, for example, a contact switch, an electromagnetic switch, an optical switch, magnetic sensor, proximity sensor, or other sensor.

It should also be understood that the locking switch 78 is an optional component and that the device can be made so that the dip switch 80 is fully operated LED Assembly 72, regardless of whether the one of the adapters 22 or 24 with the housing 12. In addition, it should be understood that the adapter 24 local lighting is an optional component, as the light from the source 14 may, in one embodiment, proceed directly from the housing without passing through the tubular configuration of the adapter 24. In this embodiment, it should be understood that the housing 10 can be mounted for use in local mode coverage by connecting structures 26 suspension to another portion of the housing 12. For example, 26 of the suspension (which may also be called a "reference design") can connect to any site of the body 12 (for example, at the intermediate or rear part of the building) by any conventional connecting device, for example bystroszhigaemoy, quarter-turn coupling, threaded coupling, clamp coupling, connection with what Atgam. In addition, the supporting structure may have a configuration different from the structure 26 of the suspension. For example, instead of providing the actual connection with the housing 12, the above-mentioned design can simply hold the housing 12 or to close it, or may simply provide a support surface on which we can build the body 12. It is assumed that the design of the suspension can contain any mechanical device that allows you to direct light emanating from the Cabinet Assembly 12. It should also be understood that, in these cases the implementation, the adapter mode panel lighting can make any design that facilitates light communication between the source 14 to the light and the light guide 16.

The figure 12 shows, in particular, a device which can easily match with the Cabinet Assembly 12. The device is a structure in the form of bags, the overall position 112. Design 112 in the form of a bag made of a suitable flexible material such as woven fabric or flexible plastic. Design 112 in the form of the bag is made with the possibility of reliable placement of Cabinet Assembly 12 and provides a convenient structure for fixing Cabinet Assembly 12 in position or carrying.

As shown in figure 12, the basic plot structure 112 in the form of handbags made p of the form for a snug fit to the surface 56 of the capture of the Cabinet Assembly 12 and the coverage of said surface. One end 113 structure 112 in the form of the bag is opened to insert in her Cabinet build its first end with a connecting place. To facilitate the installation of the Cabinet Assembly 12 through the end 113 of the structure 112 in the form of bags, you can ensure that the node 114 zipper from the end 113 inside. Node 114 zipper open, as shown in figure 12, to facilitate insertion and closed after insertion, to provide dense coverage of the surface 56 of the capture structure 112 in the form of bags, thereby reliably holding Cabinet Assembly 12.

In another embodiment, shown in Fig. 13, the zipper is not provided. Instead, the material 115 structure 112 in the form of the handbag is resilient in nature and can be stretched (like a wetsuit) to accommodate the Cabinet Assembly 12 with a snug fit.

As can be seen in figure 12, the end structures 112 in the form of bags, the opposite end of the containing hole 113 to accommodate the device has performed a hole 116, which is combined with air channels 94, when the Cabinet Assembly 12 is firmly held inside the structure 112 in the form of bags. Thus, in the Cabinet Assembly 12, is securely held inside the structure 112 in the form of bags, you can keep the free circulation of air. The hole 116 also allows the connection adapter is 22 or 24 with the Cabinet Assembly 12, securely held inside the structure 112 in the form of bags.

The figure 12 shows that the structure 112 in the form of the bag is made with a side opening 118 located with the possibility of combining with an on / off switch 80. Therefore, the user can conveniently operate the dip switch 80, when the Cabinet Assembly is securely held in the design for the bag. A similar hole (not shown) is provided for display 88.

Figure 12 also shows that the design 112 in the form of bags contains a collecting belt 120 that is attached to the outer surface of said structure. Modular belt 120 may be of any desired construction, but as shown, the belt is divided into two segments 122 and 124 of the belt. Segment 122 of the strap has one end connected with the external surface of the structure 112 in the form of bags, and contains a zipper slot 126 attached to its free end. Segment 124 of the strap has one end connected with the external surface of the structure 112 in the form of bags, and a free end that has an elastic closure 128, able to dock and be split, with the zipper slot 126.

To secure the structure in the bag two segments 122 and 124 of the belt can be disconnected from one another by uncoupling the coupled fasteners 126 and 128. Then segme what you 122 and 124 of the strap you can throw over the guide cot or something like that and then connect the fasteners 126 and 128, to thereby provide a support for held-Cabinet Assembly 12 through the guide cot or something like that. This mount provides the greatest advantage when the device 10 is used in the mode panel lighting, but can also be suitable for device 10 used in the local mode of lighting. Modular belt 120 provides the user with enough versatility in the positioning of the Cabinet Assembly 12 of the device 10 in many different places of operation. Modular belt 120 also facilitates the portability of the device 10 from place to place. Additional opportunities for a variety of applications, you can provide the connection segment of the belt structure 112 in the form of bags with zipper Velcro.

The invention is described in detail to clarify the example of variants of its implementation, which are currently considered the most useful and desirable, but it should be understood that these details are intended only for the mentioned purpose and that the invention is not limited to the described variants of implementation, but, in contrast, involves the scope of the modifications and equivalent schemes, which are within the essence and scope of the attached claims. For example, it should be understood that the present invention before olague, that, to the extent possible, at least one symptom of any option exercise can be combined with at least one symptom of any other variant implementation.

1. Phototherapeutic device for babies, containing:
Cabinet Assembly containing the connecting seat;
a light source installed in the Cabinet Assembly, the light source configured to emit light from the Cabinet Assembly;
the lock switch, perform the function of locking and unlocking the operational state of the light source;
adapter mode local lighting made with the possibility of selective detachable connection with a Cabinet Assembly in connection with the attachment of the adapter-mode local light to the connecting seat switches locking switch from the blocking configuration in debateroom configuration, and removing the adapter-mode local light switches locking switch from deblokiruyuschee configuration to the locking configuration; and
host mode panel lighting containing adapter mode panel lighting, and the adapter mode panel lighting is made with the possibility of permanent connection with the Cabinet Assembly in connection with the node of the mode panel lit the I contains fiber, connected at one end with the adapter mode panel lighting and at the opposite end from the light-emitting panel, and the node of the mode panel lighting provides light communication light guide between the light source and the light-emitting panel, when the adapter mode panel lighting attached to the connecting place.

2. Phototherapeutic device for infants according to claim 1, in which the light source is an led Assembly LED Assembly), which when the power supply provides the output intensity is higher than 55 mW/cm2/nm, service life, significantly more than 600 hours and the opportunity of light emission in the blue range of the visible spectrum.

3. Phototherapeutic device for infants according to claim 1, additionally containing a design of a suspension connected to the adapter-mode local light, for fixing Cabinet Assembly in a suspended configuration.

4. Phototherapeutic device for infants according to claim 1, additionally containing on-off switch for turning on and off the light source when either the adapter mode local lighting or adapter mode panel lighting actuates the lock switch, when this dip switch is locked when none of the adapters modes not picral the n to the connection.

5. Phototherapeutic device for infants according to claim 4, in which the light source, the locking switch and dip switch functionally connected through the controller, the controller transmits a signal to activate the light source only when the lock switch is in the released configuration, and the dip switch is in the on position.

6. Phototherapeutic device for infants according to claim 1, containing the design in the form of handbags that are made with the ability to retrieve and reliable placement of her Cabinet Assembly, without interfering with light emitted from a Cabinet Assembly of the light source; thus the design for the bag includes a mounting strap.

7. Phototherapeutic device for infants comprising: Cabinet Assembly, and
LED Assembly made with the possibility of light emission in the blue range of the visible spectrum;
this LED the Assembly is installed inside the Cabinet Assembly between its opposite ends, to emit light from one end of the Cabinet Assembly, at power up,
Cabinet Assembly has, in General, a cylindrical outer surface, but with the Central section of smaller diameter than the opposite areas of said surface, and a connecting location in the centre of the end item on which the opening to accommodate Rethimno connect adapter mode local lighting or adapter mode panel lighting.

8. Phototherapeutic device for infants according to claim 7, in which case the Assembly has an external dip switch that controls the emission of light of the LED Assembly and located to allow the capture of user external surface with one hand for effect on / off switch.

9. Phototherapeutic device for infants of claim 8, in which case the Assembly has mechanical elements at opposite ends, and a cylindrical outer surface formed by a pair of abutting Polukarov, linked among themselves and with end elements.

10. Phototherapeutic device for infants according to claim 9, in which the aforementioned abutting polakowi have mating between the edges, which serve to connect the junction Polukarov, during the mixing in the position of the interaction.

11. Phototherapeutic device for infants according to claim 9, in which the dip switch is connected to circuit boards located inside the Cabinet Assembly near the LED Assembly, with the above device further comprises a fan configured to receive power, when power is supplied to the LED Assembly, and one end of the Cabinet Assembly includes a ring section, limiting the Central passage of light in the above-mentioned t is RA and contains made the air inlet channels, the opposite end of the Cabinet Assembly includes an electrical cable, continuing through the said end face and functionally connected to the circuit Board to supply power to the LED Assembly under control of the dip switch, and the opposite end elements of Cabinet assemblies contain fulfilled in them air channels, so that when the unit fan is energized, the air could circulate through the Cabinet Assembly.

12. Phototherapeutic device for infants according to claim 11, in which phototherapy device includes structure in the form of handbags that are made with the ability to retrieve placing and maintaining in her Cabinet Assembly, and the design for the bag contains made it a hole that provides access to the dip switch, and made it vents that allow air to circulate on the said Cabinet Assembly, during its placement and support structures in the form of bags, and referred to the design as the handbag contains is connected to her belt.

13. Phototherapeutic device for infants according to claim 7, in which the mentioned phototherapeutic device includes a display that indicates the time of operation of the device.

14. Phototherapeutic device for infants according to claim 7, in which the building is owned by the Assembly includes a locking switch, in normal condition blocking the power supply in the LED Assembly, but allows the dip switch to control the power supply in the LED Assembly, when activated, these locking switch is arranged to be triggered when any of the pairs of adapters mode selectively and Rethimno connected to the Cabinet Assembly.

15. Phototherapeutic device for infants by 14 in which one of the pair of adapters includes the adapter-mode local light at selective detachable connection with the Cabinet Assembly provides in her hole, allowing phototherapy device to operate in the local illumination by means of light emission through the hole.

16. Phototherapeutic device for infants by 14 in which one of the pair of adapters includes adapter mode panel lighting connected to the elongated flexible fiber optic endoscope node and a light-emitting panel at its distal end, the light emitted from the aforementioned LED light source, is transmitted mentioned fiber optic node in the light-emitting panel, and this light-emitting panel can be directly wrap around treatment of the baby.

17. Phototherapeutic device for infants comprising:br/> Cabinet Assembly; and
LED Assembly, which when the power supply provides a light source having a power output in the blue range of the visible spectrum;
this LED the Assembly is installed inside the Cabinet Assembly between its opposite ends;
circuit Board, electrically connected with the LED Assembly installed inside the tank site near the LED assemblies;
the dip switch on the Cabinet Assembly, electrically connected with said circuit Board so as to control the supply of power to the LED Assembly;
moreover, the opposite ends of Cabinet assemblies contain fulfilled in them the intake and exhaust air ducts,
LED Assembly includes structure for mounting the LED, providing an intermediate passage between the inlet and outlet channels;
the fan is electrically connected to the circuit Board and installed in the Cabinet Assembly in a position that provides air circulation successively in the longitudinal direction of the housing through the inlet, intermediate and outlet channels; and
Cabinet Assembly has a connecting location in the centre of the end element with a hole to accommodate Rethimno connect adapter mode local lighting or adapter mode panel lighting having a tubular front section, which engages with the contact elementhandle enable LED-Assembly.

18. Phototherapeutic device for infants through 17, with phototherapeutic device also includes a digital display on a liquid crystal (LCD) display, indicating that the LED Assembly is in working condition, and the total time of operation.

19. Phototherapeutic device for babies, containing:
Cabinet Assembly;
a light source installed in the Cabinet Assembly;
host mode panel lighting containing adapter mode panel lighting made with the possibility detachable connection with the Cabinet Assembly, and the host mode panel lighting further comprises an elongated flexible light guide and the light-emitting panel, the light guide provides a light connection between the light source and the light-emitting panel so that, when the adapter mode panel lighting connected to the Cabinet Assembly, the light emitted from the light source, transmitted through the light in the light-emitting panel;
adapter mode local lighting, made with the possibility of connection with the body; and
the design of the suspension made with the possibility of hanging Cabinet Assembly,
moreover, when the adapter mode panel lighting disconnected from the Cabinet Assembly, and adapter mode local lighting disconnected from the Cabinet Assembly, the light of the body is e is emitted.

20. Phototherapeutic device for infants according to claim 19, in which the adapter-mode local light has a tubular configuration, and the light emitted by the light source can be transmitted through the adapter-mode local light, when his connection with the case.

21. Phototherapeutic device for infants according to claim 20, further containing an interlock switch associated with the light source, the light source is blocked from inclusion when the adapter mode panel lighting and the adapter-mode local light is disconnected from the housing, and the connection of any of the adapters with the body forces the locking switch to release the operation of the light source.

22. Phototherapeutic device for infants under item 21, in which the design of the suspension is connected to the adapter-mode local light.

23. Phototherapeutic device for infants according to claim 19, in which the design of the suspension contains the adapter-mode local light capable of connection to the housing when the adapter mode panel lighting detached from the housing.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly physiotherapy, and may be used for treating diabetic polyneuropathy. What is involved is a phototherapy by Bioptron-compakt III apparatus. A lamp is placed at 5 cm from an abdominal wall surface above a projection of a pancreas. A light beam containing different wave lengths within the range of 400 nm to 34000 nm are used. The power flow density is 40 mWt/cm2, the optical energy flow density is 2.4 J/cm2, the length is 4 minutes. Then, the lamp is placed at 5 cm from a surface of a back above spines on a projection of the segments T7-T9 pravertebrally from both sides for 2 min from each side. Thereafter, the lamp is placed at popliteal spaces at 5 cm to be exposed in turn for 2 min on each side. A total length of one procedure is 12 minutes, daily; the therapeutic course is 10 procedures. On the same day, an electrophoresis session is conducted through a temporary spacer with 1% placenta hydrolysate by means of Potok-1 apparatus. The current intensity is 10-15 mA, the length is 20 min. The electrodes are placed as follows: a Y-electrode (+), each of 160 cm2 is placed paravertebrally in an interscapular region at a small distance from each other, a Y-electrode (-), each of 150 cm2 is placed on gastrocnemius muscles. The therapeutic course comprises 10 daily procedures.

EFFECT: method enables recovering all the types of sensitivity within lower extremities, the functional state of the pancreas and the carbohydrate and fat metabolic processes ensured by anti-inflammatory, anti-oedema and adaptive effects.

5 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and may be used for treating the children with severe thermal injuries. There are involved the detoxification and anticoagulant therapy to create the programmable anticoagulation conditions. It is followed by a procedure of intravenous laser blood irradiation at wave length 0.63 mcm and light guide output power 2.5 mW. The first procedure of intravenous laser blood irradiation is performed for 10 minutes, with the first 5 min - at 100 Hz, and the next 5 minutes - at a frequency of 1500 Hz. Further, the procedure of intravenous laser blood irradiation is performed for 14 min, each of 7 min at frequencies of 100 Hz and 1500 Hz. The sessions of intravenous laser blood irradiation are performed every 12 hours for 5-7 days.

EFFECT: method enables reducing the level of endogenous intoxication, improving the oxygen-transport blood function, accelerating the repair processes in burn wounds and reducing the area of plastics interventions by optimising the therapy.

3 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to gynaecology, and may be used for treating dystrophic diseases of the vulva by photodynamic therapy. That is ensured by intravenous administration of Photoditazine 0.8-1.0 mg/kg, and 90-120 minutes later, it is followed by the unanesthetised light exposure on the area of the vulva in a continuous mode by a LED apparatus at wave length 660 nm. A dose of the supplied light energy is 180-250 J/cm2 for a total length of light exposure of 30-50 minutes. If the clinical symptoms of the disease appear to be persistent, the photodynamic therapy is repeated to achieve a positive therapeutic effect. With a large area of abnormality, the vulva area is divided into quadrants that are consistently exposed to light.

EFFECT: method provides a highly effective minimally invasive, organ preservation method of treating dystrophic diseases of the vulva, which provides a complete recovery of the disease; it is not accompanied by side effects, enables reducing the length of treatment, ensuring the treatment in an outpatient setting.

3 cl, 3 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to paediatrics. The exposure is generated by Bioproton apparatus radiating incoherent polarised light. On the first day, the reflex areas are exposed to red light, namely, finger tips, feet, ears for 5 seconds at a distance of 10 cm. On the second day following the similar exposure on the reflex zones, the eyes are exposed to blue, purple and green for 2 -3 seconds. On the third day, after the similar exposure on the reflex zones, the eyes are exposed to blue, yellow, green, blue, orange, red and purple for 2-3 seconds. In depression syndrome, the session is ended by the exposure to red, and in excitation syndrome - to purple. The eyes are exposed at a distance of 5 cm from the eyes. The therapeutic course is 5-15 daily procedures.

EFFECT: method extends the range of products for CNS stimulation in newborns and infants.

1 ex

FIELD: medicine.

SUBSTANCE: invention refers to phototherapeutic apparatuses. The apparatus comprises first and second central panels containing one or more UV sources, a vertical support with a rotary slide located in a guide on the vertical support with the central panel rotary mounted on the rotary slide so that the first and second central panels are arranged for treating skin of one or more parts of the body, and a carrier whereon the vertical support is fixed. According to the second version, the apparatus comprises two or more panels with UV radiation interacting via a cam; a rotary slide interacting with the panels and located in the guide along the vertical support, and the carrier with the vertical support mounted thereon.

EFFECT: use of the invention enables reducing a number of the phototherapeutic systems needed to treat multiple areas of the body.

12 cl, 14 dwg

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to ophthalmology and can be used for treatment of post-LASIK keratectasia. For this purpose in space under epithelial-stromal corneal flap round recess is made from periphery to optic zone (in central zone of cornea), into which hypotonic riboflavin solution is introduced. When thickness of cornea 400 mcm and more is reached, space is filled with 0.1% riboflavin solution on 20% solution of dextran T 500 until cornea is saturated with riboflavin. After that, ultrasonic irradiation of cornea is carried out with wavelength 365 nm with intensity 3 mW/cm2 for 30 min fractionally - 6 cycles 5 each 5 minutes long. During irradiation of cornea with ultrasonic waves riboflavin solution is instilled on cornea each 2-3 minutes, additionally riboflavin solution is introduced into recess under epithelial-stromal corneal flap each 5 minutes for constant support of riboflavin solution volume in intrastromal space.

EFFECT: method ensures increase of cornea thickness to required level due to creation of conditions for fast saturation of cornea with riboflavin solution, acceleration of healing process with reduction of risk of postoperative complications development to minimum.

1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely to andrology and urology, and may be used for stimulation of spermatogenesis in experimental animals, as well as for stimulation of spermatogenesis in other mammals, including humans. A testicle region is exposed to low-intensity laser light at wavelength 475 nm, output power 10 mWt, region distance 1 cm. The exposure lasts for 1 minute; it is daily for 10 days. A single dose makes 0.6 J/cm2.

EFFECT: method enables stimulating spermatogenesis with normal production of germ cells without the use of a drug-induced therapy due to sperm absorption of blue-spectrum light energy.

3 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to endocrinology, physiotherapy and paediatrics. According to the method, an eye region is exposed to electromagnetic waves of optical range. Wavelength is 400 to 760 nm. Pulse duration is 1 to 8 seconds. Before each procedure, the patient chooses a colour that is the most enjoyable at the moment. The colours disagreeing with a comorbidity and predominant symptoms in the clinical picture are eliminated from the range to be used. Before each procedure, a smooth or sudden increase in light intensity, brightness, flash pauses and extra eye lighting are specified individually, depending on the sensitivity of the patient's visual analyser to the illumination and rhythm preferences. After 1-2 hours, acupuncture follows. Auricular 17, 18, 26a, 28, 22, 87 and corporeal E 36, Gi 11, J 12, F 2, MC 6, RP 4, RP 6, RP 9, T 14, Gi 4, E 25, VB 20, VB 10 points are exposed. The procedures are daily, in the morning hours. The therapeutic course is 7 procedures.

EFFECT: method improves the clinical effectiveness in the patients with a predominance of complaints about obesity, insomnia, impatience, high blood pressure, memory loss, blood circulation disorders in the vertebral artery system.

3 cl, 3 ex 9 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medical equipment and aims at real-time optic pyrometer-based tissue temperature monitoring. A catheter comprises a catheter body, a distal section of a tip which includes an ablation electrode accommodating a shell and a stopper forming a cavity, and an optical fibre passing through a cavity a distal end of which is placed in a hole of the ablation electrode shell. An optic fibre provides detection of black body radiation during ablation tissue removal. The catheter is a part of systems for the detection of black-body radiation during ablation tissue removal, and for ablation removal and tissue temperature measurement. The catheter for ablation cardiac tissue removal also comprises a deflectable portion distal to the catheter body, a tip section with the electrode for RF ablation cardiac tissue removal, and an optic collector for the detection of black body radiation from cardiac tissue. This catheter is a part of the system for cardiac tissue removal and tissue temperature measurement which also contains the system of the detection of optic emission coupled with the optic collector for processing signals representing the wavelength of at least a part of black-body radiation to determine tissue temperature.

EFFECT: use of the invention enables real-time tissue temperature monitoring during the injury removal procedure to avoid the critical temperature threshold.

18 cl, 12 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medical equipment, namely to light therapeutic apparatuses. A body coating is designed for at least partial envelopment and coating of a part of a human body and/or a body support, and comprises a number of mated flexible parts of a modular coating. Each part of the modular coating comprises a flexible substrate and a number of electroluminescence sources attached to the substrate for illuminating at least a part of the human body. The flexible parts of the modular body coating are detachable and designed so that the electroluminescence sources of each part of the body coating are electrically connected to each other once said parts of the body coating are mated.

EFFECT: use of the invention enables more comfortable light therapy.

14 cl, 23 dwg

FIELD: medicine.

SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.

EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.

3 cl, 5 dwg

FIELD: medicine.

SUBSTANCE: method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm2.

EFFECT: enhanced effectiveness of treatment.

4 cl

FIELD: medicine.

SUBSTANCE: method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2 15-20 min later during 30-90 s.

EFFECT: complete destruction of neoplasm; excluded its further growth.

4 cl

FIELD: medicine.

SUBSTANCE: method involves applying transscleral diaphanoscopic examination method for adjusting intraocular neoplasm localization and size. Rectangular scleral pocket is built 2/3 times as large as sclera thickness which base is turned from the limb. Several electrodes manufactured from a metal of platinum group are introduced into intraocular neoplasm structure via the built scleral pocket. Next to it, intraocular neoplasm electrochemical destruction is carried out in changing electrodes polarity with current intensity of 100 mA during 1-10 min, and the electrodes are removed. Superficial scleral flap is returned to its place and fixed with interrupted sutures. 0.1-2% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transpupillary laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2. the operation is ended with placing sutures on conjunctiva. Platinum, iridium or rhodium are used as the metals of platinum group. The number of electrodes is equal to 4-8. 0.1-1% khlorin solution, selected from group containing photolon, radachlorine or photoditazine, is additionally repeatedly intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2.

EFFECT: complete destruction of neoplasm; excluded tumor recurrence; reduced risk of tumor cells dissemination.

3 cl, 3 dwg

FIELD: medicine.

SUBSTANCE: method involves preparation dental surface, covering it with 30% aqueous solution of silver nitrate and recovery agent for precipitating insoluble silver salts. Silver salts precipitation is carried out by exposing silver nitrate covering tooth surface with halogen radiation of the kind produced by halogen lamp of 12 W or 75 W having spectral bandwidth of 400…500 nm provided with light guide for concentrating luminous flux for 60 s.

EFFECT: enhanced effectiveness of treatment; localized treatment; reduced risk of complications and stress action upon child.

FIELD: medicine.

SUBSTANCE: the present innovation deals with treating vascular cutaneous neoplasms, such as nevus flammeus and gemangiomas. Light-thermal impact at energy ranged 39-47 J/sq. cm should be performed in two stages, and between them, 2-3 wk after the onset of vascular resistance at the first stage one should perform beta-therapy daily for 2-3 d at single dosage being 20 g. Then, 3 wk later it is necessary to conduct the second stage of light-thermal impact by starting at energy value being 42 J/sq. cm, not less. The method enables to shorten therapy terms due to applying combined method to affect vascular cutaneous neoplasms.

EFFECT: higher therapeutic and cosmetic effect.

1 ex

FIELD: medicine.

SUBSTANCE: method involves intravitreously introducing two electrodes into intraocular neoplasm after carrying out vitrectomy and retinotomy to expose the intraocular neoplasm. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with current intensity of 100 mA during 1-10 min or 10 mA during 10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2.The transformed retina and tumor destruction products are intravitreally removed. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. Another embodiment of the invention involves adjusting position and size of the intraocular neoplasm in trans-scleral diaphanoscopic way. Rectangular scleral pocket is built above the intraocular neoplasm to 2/3 of sclera thickness with its base turned away from limb. Several electrodes are introduced into intraocular neoplasm structure via the built bed. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with the same current intensity in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. Superficial scleral flat is returned to its place and fixed with interrupted sutures. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg after having carried out vitrectomy and retinotomy. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2. The transformed retina and tumor destruction products are intravitreally removed using vitreotome. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. The number of electrodes is equal to 4-8.

EFFECT: reduced risk of metastasizing.

4 cl, 13 dwg

FIELD: medicine.

SUBSTANCE: method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm2.

EFFECT: accelerated subretinal edema and hemorrhages resorption; regression and obliteration of the subretinal neovascular membrane; prolonged vision function stabilization.

6 cl

FIELD: medicine.

SUBSTANCE: method involves filling vitreous cavity with perfluororganic compound. Two electrodes manufactured from platinum group metal are intravitreally, transretinally introduced into intraocular neoplasm. Electrochemical destruction is carried out with current intensity of 10-100 mA during 1-10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2 in perfluororganic compound medium. The transformed retina and tumor destruction products are intravitreally removed with perfluororganic compound volume being compensated with its additional introduction. Boundary-making endolasercoagulation of retinotomy area is carried out. The perfluororganic compound is substituted with silicon oil. The operation is ended in placing sutures over sclerotmy areas and over conjunctiva. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity. Platinum, iridium or rhodium are used as the platinum group metals.

EFFECT: complete destruction of neoplasm; reduced dissemination risk.

6 cl, 12 dwg

FIELD: medicine, applicable for stopping of pains of various nature.

SUBSTANCE: the device has a quantum-mechanical oscillator located in a casing, magnet, vessel for medicinal agent and a hollow cylinder. The magnet is installed between the oscillator and the vessel. Positioned in the vessel is a hollow cylinder having through holes on its surface.

EFFECT: quick and absolute anestesia.

2 ex, 1 dwg

Up!